Prolactin cell subpopulations separated on discontinuous Percoll gradient: an immunocytochemical, biochemical, and physiological characterization.
A single-step procedure was devised to separate PRL cells from the rat anterior pituitary gland. After dissociation, cells were centrifuged on a Percoll gradient. Three layers were recovered. The composition of the different layers was evaluated using immunocytochemistry (with antisera to the six pituitary hormones), and in situ hybridization [with DNA complementary to PRL or to GH messenger RNA (mRNA)]. Both methods yielded identical values. PRL cells were recovered in the lower density layer (layer 1) with a good yield (that is 81% of the total PRL cells of the initial cell suspension) and in addition, markedly enriched (indeed 85% of the cells in layer 1 stained for PRL). A second layer (layer 2: intermediate density) contained most of the remaining PRL cells which were, however, heavily contaminated mainly by GH cells and cells that did not stain for any of the known pituitary hormones. A third layer (layer 3: higher density) was enriched in GH cells to 93% (representing, however, only 10% of the initial pituitary GH cells). In addition, PRL and GH were measured by RIA in culture medium and in cell lysates. Hormone biosynthesis was monitored by polyacrylamide gel electrophoresis and autoradiography after culture in the presence of [35S]methionine. These experiments confirmed that layer 1 was enriched in cells containing, and producing, PRL and depleted from GH cells. Cells in layer 2 contained and produced more GH than PRL. PRL cells from layer 1 responded to dopamine and to vasoactive intestinal polypeptide in the same way as PRL cells in the unseparated pituitary cell population. In contrast PRL cells in layer 2 had a lower basal secretion rate but a higher response to vasoactive intestinal polypeptide. Unless this represents a paracrine effect of non-PRL cells, PRL cells in layer 2 exhibit different properties and may therefore form a distinct subpopulation of PRL cells.
Velkeniers
B
B
Department of Pharmacology, Medical School, Vrije Universiteit, Brussel, Belgium.
Hooghe-Peters
E L
EL
Hooghe
R
R
Belayew
A
A
Smets
G
G
Claeys
A
A
Robberecht
P
P
Vanhaelst
L
L
D000818:Animals; D002469:Cell Separation / Q000379:methods; D002478:Cells, Cultured; D002501:Centrifugation, Zonal / Q000379:methods; D003001:Cloning, Molecular; D004247:DNA / Q000235:genetics / Q000302:isolation & purification; D005260:Female; D013006:Growth Hormone / Q000032:analysis; D009693:Nucleic Acid Hybridization; D010903:Pituitary Gland, Anterior / Q000166:cytology* / Q000502:physiology; D010908:Pituitary Hormones, Anterior / Q000032:analysis; D011205:Povidone; D011388:Prolactin / Q000032:analysis* / Q000235:genetics; D051381:Rats; D011919:Rats, Inbred Strains; D012822:Silicon Dioxide
D010908:Pituitary Hormones, Anterior; C016039:Percoll; D012822:Silicon Dioxide; D011388:Prolactin; D013006:Growth Hormone; D004247:DNA; D011205:Povidone